Pauline Godoi Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pauline Godoi Silva has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Adan Rodrigues de Oliveira
Laboratório de Engenharia Biológica, Instituto de Ciências Biológicas, Universidade Federal do Pará Belém Pará Brazil
3 shared publications - Antonio Sergio Dacome
Biochemistry Department, State University of Maringá (UEM), Jardim Universitário, Maringá, Paraná, Av. Colombo, 5790, Brazil
3 shared publications - Eduardo Jorge Pilau
Laboratory of Biomolecules and Mass Spectrometry, Department of Chemistry, State University of Maringá, Maringá 87080-000, Paraná, Brazil
3 shared publications - Felipe de Oliveira Souza
Department of Chemistry, State University of Maringá, Maringá, PR, Brazil
3 shared publications - Maria Rosa Trentin Zorzenon
Biochemistry Department, State University of Maringá (UEM), Jardim Universitário, Maringá, Paraná, Av. Colombo, 5790, Brazil
3 shared publications - Milena Kazue Enokida
Biochemistry Department, State University of Maringá (UEM), Jardim Universitário, Maringá, Paraná, Av. Colombo, 5790, Brazil
3 shared publications
Latest Publications
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (4) , 1-13
Stevia By-product Fraction has Antioxidant Capacity and has been Evaluated for its Antihyperglycemic and Antilipid Potential
Introduction/Objective: The ethanolic pretreatment of stevia leaves is considered ecologically favorable and increases its yield, purity level, and sensory profile of sweeteners. We investigated the by-product generated so that we can provide a viable and applicable destination to effectively contribute to the production and industrial chain of stevia sweeteners. Recently, an antioxidant and antidiabetic fraction was obtained through stevia methanolic extraction. However, this process is costly, has a low yield, and is non-green. In this study, we got an antioxidant fraction of stevia from its pretreatment by-product, the ethanolic extract, characterized its bioactive compounds – mainly phenolic acids and flavonoids – and evaluated its antidiabetic and antilipid capacity. Methods: The ethanolic extract was fractionated, then the ethyl acetate fraction was microencapsulated. Physicochemical, Mass Spectrometry (UHPLC/MS-MS), scanning electron microscopy, microencapsulation efficiency, and antioxidant capacity analyses were carried out. The antioxidant capacity was evaluated. Antihyperglycemic capacity was assessed by inhibition of α-glucosidase and α-amylase. For antilipid potential, inhibition of pancreatic lipase was measured. Results: Antioxidant potential was observed mainly in the fraction. Microencapsulation improved the stability of the fraction. Mass spectrometry allowed comparison with phenolic and flavonoid compounds from the methanolic and ethanolic fractions of the by-product. Many compounds were coincident, which may explain the similar antioxidant capacity found. The samples showed more than 90% inhibition of alpha-glucosidase, which may indicate potential antidiabetic activity. All samples showed inhibition of the pancreatic lipase enzyme higher than 80%, reaching 91.05% for the free fraction. Conclusion: This study represented the recovery of a by-product and showed that this antioxidant fraction deserves further investigation for its bioactive potential, especially antioxidant, antidiabetic, and anti-lipid.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (4) , 1-13
Stevia By-product Fraction has Antioxidant Capacity and has been Evaluated for its Antihyperglycemic and Antilipid Potential
Introduction/Objective: The ethanolic pretreatment of stevia leaves is considered ecologically favorable and increases its yield, purity level, and sensory profile of sweeteners. We investigated the by-product generated so that we can provide a viable and applicable destination to effectively contribute to the production and industrial chain of stevia sweeteners. Recently, an antioxidant and antidiabetic fraction was obtained through stevia methanolic extraction. However, this process is costly, has a low yield, and is non-green. In this study, we got an antioxidant fraction of stevia from its pretreatment by-product, the ethanolic extract, characterized its bioactive compounds – mainly phenolic acids and flavonoids – and evaluated its antidiabetic and antilipid capacity. Methods: The ethanolic extract was fractionated, then the ethyl acetate fraction was microencapsulated. Physicochemical, Mass Spectrometry (UHPLC/MS-MS), scanning electron microscopy, microencapsulation efficiency, and antioxidant capacity analyses were carried out. The antioxidant capacity was evaluated. Antihyperglycemic capacity was assessed by inhibition of α-glucosidase and α-amylase. For antilipid potential, inhibition of pancreatic lipase was measured. Results: Antioxidant potential was observed mainly in the fraction. Microencapsulation improved the stability of the fraction. Mass spectrometry allowed comparison with phenolic and flavonoid compounds from the methanolic and ethanolic fractions of the by-product. Many compounds were coincident, which may explain the similar antioxidant capacity found. The samples showed more than 90% inhibition of alpha-glucosidase, which may indicate potential antidiabetic activity. All samples showed inhibition of the pancreatic lipase enzyme higher than 80%, reaching 91.05% for the free fraction. Conclusion: This study represented the recovery of a by-product and showed that this antioxidant fraction deserves further investigation for its bioactive potential, especially antioxidant, antidiabetic, and anti-lipid.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (4) , 1-14
A Comparison between Microcapsules of Antioxidant Fraction of Stevia: An Evaluation of Physicochemical Parameters, Stability, Bioaccessibility, and Antidiabetic Capacity
Introduction: The antioxidant fraction of Stevia rebaudiana has important antidiabetic potential, is poorly soluble, and has low stability, which makes its applicability difficult. Materials and Methods: In this study, Stevia's fraction was obtained, characterized by Ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLCMS/ MS), and microencapsulated with maltodextrin (MDF), gum arabic (GAF), whey protein + maltodextrin (MDWF), and whey protein + gum arabic (GAWF). Then, the following parameters were evaluated: stability and antioxidant capacity over 30 days, physicochemical characteristics, preservation of bioactive compounds by digestion, and in vitro antidiabetic activity. Results and Discussion: The microcapsule with gum arabic showed better microencapsulation efficiency, while its version with maltodextrin provided increased solubility. Microencapsulation reduced the humidity and water activity in the microcapsules, except for the microcapsules containing gum arabic. The combination of maltodextrin and whey protein showed greater luminosity and a whiter powder. The microcapsules with maltodextrin and its mixture with gum arabic kept the phenolic compounds stable for 30 days. The microencapsulation with whey protein increased the antioxidant activity after 15 days of the process and during in vitro digestion. All samples showed 96% inhibition of the α-glucosidase enzyme, and only the microcapsule with maltodextrin inhibited α-amylase (58%). Conclusion: This study showed paramount results so that Antioxidant Stevia Fraction (ASF) can effectively be an adjuvant product to prevent and treat diabetes.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (4) , 1-14
A Comparison between Microcapsules of Antioxidant Fraction of Stevia: An Evaluation of Physicochemical Parameters, Stability, Bioaccessibility, and Antidiabetic Capacity
Introduction: The antioxidant fraction of Stevia rebaudiana has important antidiabetic potential, is poorly soluble, and has low stability, which makes its applicability difficult. Materials and Methods: In this study, Stevia's fraction was obtained, characterized by Ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLCMS/ MS), and microencapsulated with maltodextrin (MDF), gum arabic (GAF), whey protein + maltodextrin (MDWF), and whey protein + gum arabic (GAWF). Then, the following parameters were evaluated: stability and antioxidant capacity over 30 days, physicochemical characteristics, preservation of bioactive compounds by digestion, and in vitro antidiabetic activity. Results and Discussion: The microcapsule with gum arabic showed better microencapsulation efficiency, while its version with maltodextrin provided increased solubility. Microencapsulation reduced the humidity and water activity in the microcapsules, except for the microcapsules containing gum arabic. The combination of maltodextrin and whey protein showed greater luminosity and a whiter powder. The microcapsules with maltodextrin and its mixture with gum arabic kept the phenolic compounds stable for 30 days. The microencapsulation with whey protein increased the antioxidant activity after 15 days of the process and during in vitro digestion. All samples showed 96% inhibition of the α-glucosidase enzyme, and only the microcapsule with maltodextrin inhibited α-amylase (58%). Conclusion: This study showed paramount results so that Antioxidant Stevia Fraction (ASF) can effectively be an adjuvant product to prevent and treat diabetes.
- 30 January 2024
- Published by Elsevier in Food Bioscience
- Vol. 58
Methanolic and hydroalcoholic extract of stevia stems have antihyperglycemic and antilipid activity
- 30 January 2024
- Published by Elsevier in Food Bioscience
- Vol. 58
Methanolic and hydroalcoholic extract of stevia stems have antihyperglycemic and antilipid activity
- Open Access
- 1 January 2023
- Published by Synapse Editora
- p. 112-127
INOVAÇÕES E NOVAS FORMAS DE APROVEITAMENTO DE RESÍDUOS DE COCOS NUCÍFERA EM DIFERENTES INDÚSTRIAS - UMA REVISÃO
- 1 January 2023
- Published by Synapse Editora
- p. 112-127
Open AccessINOVAÇÕES E NOVAS FORMAS DE APROVEITAMENTO DE RESÍDUOS DE COCOS NUCÍFERA EM DIFERENTES INDÚSTRIAS - UMA REVISÃO
- Open Access
- 17 October 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (14)
O uso de amido como proposta para embalagens biodegradáveis – Uma revisão
Apesar das embalagens plásticas serem parte da vida do homem, muito tem-se falado em alternativas para substituir a produção das que são provenientes do petróleo. Como estratégia interessante, o amido, em especial, o de mandioca se destaca como fonte biodegradável, que quando comparado com o material de origem fóssil apresenta alta biodegradabilidade e vantagens mediante ao uso. Muitos estudos já demonstraram algumas vantagens e limitações desta matéria-prima, contudo, mais informações acerca do tema se torna relevante uma vez que, o Brasil é um grande produtor de amido e a produção de embalagens renováveis é de interesse mundial. Assim, o objetivo desta revisão bibliográfica narrativa foi abordar sobre as embalagens biodegradáveis como alternativa promissora para conter o avanço desenfreado da produção de lixo não degradável, demonstrando diferentes aplicações de filmes e revestimentos comestíveis de caráter biodegradável à base de amido de mandioca. Nesse contexto, diversos achados atuais foram inseridos nesta revisão para expor o conceito das embalagens biodegradáveis, além de demonstrar que a biodegradabilidade de uma embalagem pode ser afetada pelas características do polímero utilizado, e nesse sentido o amido demonstrou um tempo de degradação menor do que outros materiais poliméricos e vantagens para seu uso em embalagens. Assim, esta revisão pode servir para uma ampla gama de oportunidade de conhecer o amido de mandioca como biopolímero disponível a ser utilizado em escala industrial, garantindo assim uma maior biodegradabilidade de materiais provenientes desta matriz polimérica e consequentemente uma menor dano ao ambiente.
- 17 October 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (14)
Open AccessO uso de amido como proposta para embalagens biodegradáveis – Uma revisão
Apesar das embalagens plásticas serem parte da vida do homem, muito tem-se falado em alternativas para substituir a produção das que são provenientes do petróleo. Como estratégia interessante, o amido, em especial, o de mandioca se destaca como fonte biodegradável, que quando comparado com o material de origem fóssil apresenta alta biodegradabilidade e vantagens mediante ao uso. Muitos estudos já demonstraram algumas vantagens e limitações desta matéria-prima, contudo, mais informações acerca do tema se torna relevante uma vez que, o Brasil é um grande produtor de amido e a produção de embalagens renováveis é de interesse mundial. Assim, o objetivo desta revisão bibliográfica narrativa foi abordar sobre as embalagens biodegradáveis como alternativa promissora para conter o avanço desenfreado da produção de lixo não degradável, demonstrando diferentes aplicações de filmes e revestimentos comestíveis de caráter biodegradável à base de amido de mandioca. Nesse contexto, diversos achados atuais foram inseridos nesta revisão para expor o conceito das embalagens biodegradáveis, além de demonstrar que a biodegradabilidade de uma embalagem pode ser afetada pelas características do polímero utilizado, e nesse sentido o amido demonstrou um tempo de degradação menor do que outros materiais poliméricos e vantagens para seu uso em embalagens. Assim, esta revisão pode servir para uma ampla gama de oportunidade de conhecer o amido de mandioca como biopolímero disponível a ser utilizado em escala industrial, garantindo assim uma maior biodegradabilidade de materiais provenientes desta matriz polimérica e consequentemente uma menor dano ao ambiente.
- Open Access
- 6 August 2022
- Published by Elsevier in Applied Food Research
- Vol. 2 (2) , 100188
Aquafaba powder, lentil protein and citric acid as egg replacer in gluten-free cake: A model approach
- 6 August 2022
- Published by Elsevier in Applied Food Research
- Vol. 2 (2) , 100188
Open AccessAquafaba powder, lentil protein and citric acid as egg replacer in gluten-free cake: A model approach
- 1 January 2019
- Published by Brazilian Journal of Development in Brazilian Journal of Development
- Vol. 5 (7) , 8062-8073
Substituição de leite em pó por concentrado proteico de soro de leite (WPC - WheyProteinConcentrate) na elaboração de bolo sem glúten
Substituição de leite em pó por concentrado proteico de soro de leite (WPC – WheyProteinConcentrate) na elaboração de bolo sem glúten / Replacement of powdered milk for whey protein concentrate (WPC – WheyProteinConcentrate) in the preparation of gluten-free cake
- 1 January 2019
- Published by Brazilian Journal of Development in Brazilian Journal of Development
- Vol. 5 (7) , 8062-8073
Substituição de leite em pó por concentrado proteico de soro de leite (WPC - WheyProteinConcentrate) na elaboração de bolo sem glúten
Substituição de leite em pó por concentrado proteico de soro de leite (WPC – WheyProteinConcentrate) na elaboração de bolo sem glúten / Replacement of powdered milk for whey protein concentrate (WPC – WheyProteinConcentrate) in the preparation of gluten-free cake